Agile Therapeutics Inc

NASDAQ:AGRX  
1.15
-0.05 (-4.17%)
5:21:31 PM EDT: $1.15 0.00 (0.00%)
Officer Changes, Other Pre-Announcement

Agile Therapeutics CFO Notified Co That He Will Voluntarily Resign To Retire

Published: 05/23/2022 13:23 GMT
Agile Therapeutics Inc (AGRX) - Agile Therapeutics - CFO Dennis P. Reilly Notified Company That He Will Voluntarily Resign From His Position in Order to Retire.
Agile Therapeutics Inc - to Appoint Jason Butch to Serve As Principal Financial Officer.
Agile Therapeutics Inc - Expects Total Cycles of Twirla(reg) in Range of 20,000 to 22,000 in Q2 of 2022.
Agile Therapeutics Inc - Projects Operating Expenses for Q2 of 2022 in Range of $12.5 Million to $13.5 Million.